Talking about assisted reproductive techniques and thromboembolic risk: everything we always wanted to know

Submitted: 15 June 2022
Accepted: 1 August 2022
Published: 13 September 2022
Abstract Views: 2040
PDF: 181
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


  • Giovanni Tiscia Thrombosis and Hemostasis Unit, “Casa Sollievo della Sofferenza” Foundation, San Giovanni Rotondo, Italy.
  • Elvira Grandone Thrombosis and Hemostasis Unit, “Casa Sollievo della Sofferenza” Foundation, San Giovanni Rotondo, Italy; Obstetrics and Gynecology, University of Foggia, Italy; Ob/Gyn Department of the First I.M. Sechenov Moscow State Medical University, Moscow, Russian Federation.

The last report on Assisted Reproductive Technologies (ART) showed a steady increase in the annual number of treatment cycles worldwide. The most common techniques of autologous ART - in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) - require the use of exogenous gonadotropins with possible adverse effects [...].



PlumX Metrics


Download data is not yet available.


Chambers GM, Dyer S, Zegers-Hochschild F, et al. International Committee for Monitoring Assisted Reproductive Technologies world report: assisted reproductive technology. Hum Reprod 2021;36:2921-34. doi: 10.1093/humrep/deab198. PMID: 34601605. DOI:
Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv 2018;2:3317-59. doi: 10.1182/bloodadvances.2018024802. PMID: 30482767; PMCID: PMC6258928. DOI:
Royal College of Obstetricians and Gynaecologists. The Management of Ovarian Hyperstimulation Syndrome. Green-top Guideline No. 5. London: RCOG; 2016.
Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 2002;8:559-77. doi: 10.1093/humupd/8.6.559. PMID: 12498425. DOI:
Piazza G. Oh Heavy Burden: Recognizing the Risk of Venous Thromboembolism in Women Undergoing Assisted Reproduction. Thromb Haemost 2018;118:2011-13. doi: 10.1055/s-0038-1676073. PMID: 30453350. DOI:
Zohav E, Almog B, Cohen A, et al. A New Perspective on the Risk of Hypercoagulopathy in Ovarian Hyperstimulation Syndrome Using Thromboelastography. Reprod Sci 2017;24(12):1600-06. doi: 10.1177/1933719117697257. PMID: 28299993. DOI:
Grandone E, Di Micco PP, Villani M, et al. Venous Thromboembolism in Women Undergoing Assisted Reproductive Technologies: Data from the RIETE Registry. Thromb Haemost 2018; 118:1962-68. doi: 10.1055/s-0038-1673402. PMID: 30296817. DOI:
Sennström M, Rova K, Hellgren M, et al. Thromboembolism and in vitro fertilization - a systematic review. Acta Obstet Gynecol Scand 2017;96:1045-52. doi: 10.1111/aogs.13147. PMID: 28382684. DOI:
Villani M, Favuzzi G, Totaro P, et al. Venous thromboembolism in assisted reproductive technologies: comparison between unsuccessful versus successful cycles in an Italian cohort. J Thromb Thrombolysis 2018;45:234-39. doi: 10.1007/s11239-017-1584-z. PMID: 29170876. DOI:
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018;39:3165-41. DOI:
Piazza G, Grandone E. Thrombophilia, Antithrombotic Therapy, and Recurrent Pregnancy Loss: A Call for Pragmatism in the Face of Unknowns. Semin Reprod Med 2021;39:167-69. doi: 10.1055/s-0041-1735628. DOI:

How to Cite

Tiscia, G., & Grandone, E. (2022). Talking about assisted reproductive techniques and thromboembolic risk: everything we always wanted to know. Bleeding, Thrombosis and Vascular Biology, 1(2).